Catalina Capital Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-870
Closed -$271K 168
2025
Q1
$271K Sell
870
-1,555
-64% -$459K 0.18% 119
2024
Q4
$632K Buy
2,425
+95
+4% +$28.2K 0.21% 99
2024
Q3
$751K Buy
2,330
+213
+10% +$69.7K 0.25% 83
2024
Q2
$661K Buy
2,117
+117
+6% +$34.4K 0.25% 85
2024
Q1
$569K Buy
2,000
+788
+65% +$231K 0.24% 87
2023
Q4
$349K Buy
+1,212
New +$330K 0.23% 82

Other funds holding AMGN

Catalina Capital Group's AMGN Position: Q2 2025 in Review

Catalina Capital Group sold out of Amgen (AMGN) in Q2 2025, closing a stake of 870 shares — an estimated $271K sold.

Catalina Capital Group first reported a position in AMGN in Q4 2023 and held it in 6 quarters. The position peaked at $751K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Catalina Capital Group reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Catalina Capital Group sold 870 Amgen shares in Q2 2025, an estimated $271K.
  • Catalina Capital Group first reported a position in Amgen in Q4 2023 and held it in 6 quarters.
  • Catalina Capital Group's Amgen position peaked at $751K in Q3 2024.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Catalina Capital Group's 13F filing for Q2 2025, filed 21 Jul 2025.